Keyphrases
Secondary Prevention
100%
Nova Scotia
100%
Quebec
100%
Canadian Provinces
100%
Acute Myocardial Infarction
100%
British Columbia
87%
Utilization Rate
75%
Angiotensin-converting Enzyme Inhibitor (ACEi)
50%
Statins
50%
Beta-blockers
37%
Nitrate
25%
Regional Variation
25%
Calcium Channel Blockers
25%
Cardiac Medications
25%
Population-based
12%
Temporal Trends
12%
Administrative Database
12%
Acute Hospital
12%
Population Analysis
12%
Elderly Patients
12%
Clinical Registry
12%
Medication Use
12%
At Discharge
12%
Myocardial Infarction Patients
12%
Elderly Survivors
12%
Outpatient Use
12%
Medicine and Dentistry
Drug Therapy
100%
Secondary Prevention
100%
ACE Inhibitor
100%
Acute Heart Infarction
100%
Statin
100%
Beta Adrenergic Receptor Blocking Agent
75%
Calcium Channel Blocking Agent
50%
Nitric Acid Derivative
50%
Outpatient
25%
Emergency Care
25%
Elderly Patient
25%
Pharmacology, Toxicology and Pharmaceutical Science
Agrotis
100%
Acute Heart Infarction
100%
Dipeptidyl Carboxypeptidase Inhibitor
50%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
50%
Beta Adrenergic Receptor Blocking Agent
37%
Calcium Channel Blocker
25%
Nitric Acid Derivative
25%